Clinical TrialsSearch results
Number of results: 318
Other
- Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies
- IgG4+MOLPS, Castleman's disease, other polyclonal hypergammopathies, male Sjogen's syndrome
- Kanazawa Medical University
- 2009-08-10
Other
- A study on measurement of KP-103 concentration in nails (Phase I) - Investigation of KP-103 concentration in nails following repeated topical application to toenails in patients with onychomycosis -
- Onychomycosis
- KAKEN PHARMACEUTICAL CO.,LTD.
- 2009-05-08
Other
- Therapeutic exploratory study of KCB-1B for patients with tibial shaft fracture
- Tibial shaft fracture
- Kaken Pharmaceutical Co.,Ltd.
- 2007-10-11
Other
- Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- Acquired degenerative lumbar spinal canal stenosis
- KAKEN PHARMACEUTICAL CO., LTD.
- 2009-03-30
Other
- Trial in diabetic ulcer Using basic Fibroblast Growth Factor(KCB-1)
- Diabetic ulcer
- KAKEN PHARMACEUTICAL CO., LTD.
- 2007-09-21
Other
- Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion
- Patients with macular edema from branch retinal vein occlusion
- Kagoshima University Graduate School of Medical and Dental Sciences
- 2006-06-30
Other
- Compliance study Medication Event Monitoring System-Utilizing Survey on Bisphosphonate Compliance in Osteoporotic Patients in Japan
- Osteoporotic
- JOCC [Japan Osteoporosis Central-committee for Compliance study]
- 2007-06-30
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Recruiting
- A Phase 3, Double-Blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
- Anemia associated with myelofibrosis
- Jin Hayakawa
- 2021-01-15